72 related articles for article (PubMed ID: 9314996)
1. Quantification of tumor reoxygenation during accelerated radiation therapy.
Kocher M; Treuer H; Müller RP
Radiology; 1997 Oct; 205(1):263-8. PubMed ID: 9314996
[TBL] [Abstract][Full Text] [Related]
2. Reoxygenation of hypoxic cells by tumor shrinkage during irradiation. A computer simulation.
Kocher M; Treuer H
Strahlenther Onkol; 1995 Apr; 171(4):219-30. PubMed ID: 7740410
[TBL] [Abstract][Full Text] [Related]
3. A voxel-based multiscale model to simulate the radiation response of hypoxic tumors.
Espinoza I; Peschke P; Karger CP
Med Phys; 2015 Jan; 42(1):90-102. PubMed ID: 25563250
[TBL] [Abstract][Full Text] [Related]
4. Oxygenation of spontaneous canine tumors during fractionated radiation therapy.
Achermann RE; Ohlerth SM; Rohrer Bley C; Gassmann M; Inteeworn N; Roos M; Schärz M; Wergin MC; Kaser-Hotz B
Strahlenther Onkol; 2004 May; 180(5):297-305. PubMed ID: 15127160
[TBL] [Abstract][Full Text] [Related]
5. Effect on regrowth delay in a murine tumor of scheduling split-dose irradiation based on direct pO2 measurements by electron paramagnetic resonance oximetry.
O'Hara JA; Goda F; Demidenko E; Swartz HM
Radiat Res; 1998 Nov; 150(5):549-56. PubMed ID: 9806597
[TBL] [Abstract][Full Text] [Related]
6. Monte Carlo radiotherapy simulations of accelerated repopulation and reoxygenation for hypoxic head and neck cancer.
Harriss-Phillips WM; Bezak E; Yeoh EK
Br J Radiol; 2011 Oct; 84(1006):903-18. PubMed ID: 21933980
[TBL] [Abstract][Full Text] [Related]
7. A rationale for fractionation for slowly proliferating tumors such as prostatic adenocarcinoma.
Fowler JF; Ritter MA
Int J Radiat Oncol Biol Phys; 1995 May; 32(2):521-9. PubMed ID: 7751194
[TBL] [Abstract][Full Text] [Related]
8. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
Chen GY; Jiang GL; Wang LJ; Qian H; Fu XL; Yang H; Wu KL; Zhao S
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):70-5. PubMed ID: 15629596
[TBL] [Abstract][Full Text] [Related]
10. [Reoxygenation in Yoshida sarcoma during different fractionated radiotherapy].
Strnad V; Kamprad F; Jahns J; Kirschner M; Meyer M; Madaj-Sterba P; Riepl M; Böhme R; Sauer R
Strahlenther Onkol; 1996 Nov; 172(11):619-25. PubMed ID: 8975393
[TBL] [Abstract][Full Text] [Related]
11. Changes in tumor cell response due to prolonged dose delivery times in fractionated radiation therapy.
Paganetti H
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):892-900. PubMed ID: 16199319
[TBL] [Abstract][Full Text] [Related]
12. The influence of radiation dose on the magnitude and kinetics of reoxygenation in a C3H mammary carcinoma.
Grau C; Overgaard J
Radiat Res; 1990 Jun; 122(3):309-15. PubMed ID: 2356285
[TBL] [Abstract][Full Text] [Related]
13. [Escalated hyperfractionated accelerated radiation therapy combined with chemotherapy for stage IIIB non-small cell lung cancer].
Zhao L; Zhang F; Wu H; Wu Q; He X
Zhongguo Fei Ai Za Zhi; 2002 Dec; 5(6):420-2. PubMed ID: 21333220
[TBL] [Abstract][Full Text] [Related]
14. Escalated hyperfractionated accelerated radiation therapy for locally advanced non-small cell lung cancer: a clinical phase II trial.
Chen GY; Jiang GL; Qian H; Wang LJ; Yang HJ; Fu XL; Wu KL; Zang Z; Zhao S
Radiother Oncol; 2004 May; 71(2):157-62. PubMed ID: 15110448
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity in the fractionation sensitivities of human tumor cell lines: studies in a three-dimensional model system.
Stuschke M; Budach V; Stüben G; Streffer C; Sack H
Int J Radiat Oncol Biol Phys; 1995 May; 32(2):395-408. PubMed ID: 7751182
[TBL] [Abstract][Full Text] [Related]
16. Local control of carcinoma of the tonsil by radiation therapy: an analysis of patterns of fractionation in nine institutions.
Withers HR; Peters LJ; Taylor JM; Owen JB; Morrison WH; Schultheiss TE; Keane T; O'Sullivan B; van Dyk J; Gupta N
Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):549-62. PubMed ID: 7558943
[TBL] [Abstract][Full Text] [Related]
17. Effect of docetaxel on the therapeutic ratio of fractionated radiotherapy in vivo.
Mason KA; Kishi K; Hunter N; Buchmiller L; Akimoto T; Komaki R; Milas L
Clin Cancer Res; 1999 Dec; 5(12):4191-8. PubMed ID: 10632360
[TBL] [Abstract][Full Text] [Related]
18. Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions.
Lee CG; Heijn M; di Tomaso E; Griffon-Etienne G; Ancukiewicz M; Koike C; Park KR; Ferrara N; Jain RK; Suit HD; Boucher Y
Cancer Res; 2000 Oct; 60(19):5565-70. PubMed ID: 11034104
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
20. Reoxygenation of human coronary smooth muscle cells suppresses HIF-1alpha gene expression and augments radiation-induced growth delay and apoptosis.
Grumann T; Arab A; Bode C; Guttenberger R; Hehrlein C
Strahlenther Onkol; 2006 Jan; 182(1):16-21. PubMed ID: 16404516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
